ASM Microbe 2017 Final Program 

ASM Microbe 2017 Exhibit and Poster Hall Activity Guide 

Claim CE Credit

Purchase Session Recordings


Ernest N. Morial Convention Center
900 Convention Center Blvd.
New Orleans, LA 70130

"The Microbe 2016 meeting was of a very high quality. There were many sessions that fundamentally informed the work I do in a diagnostic microbiology laboratory."
Susan Benson, Clinical Microbiologist, Pathwest

General Sessions

Opening Session
Future of ASM and President's Forum
Keynote Address

June 1, 2017
5:00 p.m. - 6:45 p.m.

Opening Session 

Nicole Dubilier; Program Committee Co-chair; Max Planck Inst. of Marine Microbiol., Bremen, Germany
Robin Patel; Program Committee Co-chair; Mayo Clinic, Rochester, MN

Susan E. Sharp; Kaiser Permanente - Northwest, Portland, OR


Julie Theriot newJulie Theriot; Stanford Univ., Stanford, CA

Julie Theriot has been on the faculty of the Stanford University School of Medicine since 1997, with appointments in the Department of Biochemistry and the Department of Microbiology & Immunology, and is currently an Investigator of the Howard Hughes Medical Institute.  The experimental work of her research group focuses on quantitative measurement of the dynamic and mechanical behavior of structural components in living cells, exploring the molecular and biophysical mechanisms of various forms of cell motility and shape determination across a variety of bacterial and eukaryotic cell types.  Theriot has won numerous awards for her research, including the David and Lucile Packard Foundation Fellowship for Science and Engineering and the John D. and Catherine T. MacArthur Foundation Fellowship.  She has also received multiple teaching awards from both M. D. and Ph. D. students at Stanford.  She is a coauthor of the textbook Physical Biology of the Cell.

Lalita RamakrishnanLalita Ramakrishnan; Univ. of Cambridge, Cambridge, United Kingdom

Lalita Ramakrishnan is a professor of immunology and infectious diseases at the University of Cambridge in the United Kingdom. Prior to her current position, she served as an Attending Physician for Infectious Diseases Consultation at the University of Washington Hospital. She has received more than 10 honors and awards, including appointment to the U.S. National Academy of Sciences in 2015. Additionally, she has been a reviewer for more than 25 journals including Cell, Molecular Cell, Nature, Science, Nature Medicine, Nature Immunology, Immunity, Cell Host and Microbe, Cell Reports, Science Translational Medicine and PNAS. 

ASM Microbe Lecturer:

Nick LaneNick Lane; Univ. Coll. London, London, United Kingdom

Dr. Nick Lane is a professor of evolutionary biochemistry in the Department of Genetics, Evolution and Environment at University College London. His research is on bioenergetic constraints on cell structure and evolution. Dr. Lane is Co-Director of the new Centre for Life’s Origins and Evolution (CLOE) at UCL and was a founding member of the UCL Consortium for Mitochondrial Research. His work has been recognized by several awards, including the Biochemical Society Award in 2015 and the Royal Society Michael Faraday Prize in 2016. He has published some 80 research papers and articles, co-edited two volumes and written four celebrated books for the general public, which have been translated into 25 languages – Oxygen (OUP, 2002), Power, Sex, Suicide (OUP, 2005), Life Ascending (WW Norton 2009) and The Vital Question (WW Norton, 2015). Life Ascending won the Royal Society Prize for Science Books in 2010, while Bill Gates described The Vital Question as “an amazing inquiry into the origins of life."

June 2, 2017
11:00 a.m. - 12:30 p.m.

Future of ASM and President's Forum

Susan E. Sharp; Kaiser Permanente - Northwest, Portland, OR

Future of ASM
Susan E. Sharp; Kaiser Permanente - Northwest, Portland, OR
Stefano Bertuzzi; American Society for Microbiol., Washington, DC

President's Forum

Heidi NelsonHeidi Nelson; Mayo Clinic, Rochester, MN

Heidi Nelson, MD, is the the Program Director of the Mayo Clinic Center for Individualized Medicine (CIM) Microbiome Program and Chair of the Department of Surgery. As leader of the Mayo Microbiome Program, she has focused her work on ensuring that the program infrastructure provides comprehensive as well as reliable/reproducible methodologic platforms. Specifically, she recruited and worked with key scientists and laboratory personnel to develop and standardize microbiome methods from sample collection and sequencing to analytics and complex modeling. The program has properly equipped and resourced core facilities that can support everything from computational modeling to germ free experimentation and human clinical trials. Microbiome work fits with her long standing research interest in colorectal cancer. She serves as the national PI and NCI-grant PI for the NIH-funded colon cancer trial, for evaluating the role of laparoscopic surgery in colorectal cancer treatment. Leadership roles have included the Mayo Clinic Cancer Center and the NCI Cooperative Groups. Additionally, she has been Vice Chair of the North Central Cancer Treatment Group and Group Co-Chair of American College of Surgeons Oncology Group. She also has been faculty for the AACR/ASCO Methods in Clinical Cancer Research Workshop and a member and then chair of two NIH (NCI) study sections including, Subcommittee H (Cooperative Group Study Section), Clinical Oncology (CONC) as well as a member of the NCI Clinical Trials Advisory Committee. 

Christopher WoodsChristopher W. Woods; Duke Univ. Med. Ctr., Durham, NC

Dr. Woods is a professor in the Departments of Medicine and Pathology at Duke University, adjunct associate professor in Epidemiology at the University of North Carolina-Chapel Hill School of Public Health, and adjunct associate professor in the Emerging Infections Program at the Duke-National University of Singapore Graduate Medical School. He is Co-Director of the Hubert-Yeargan Center for Global Health, and Associate Director for Applied Genomics in the Duke Center for Applied Genomics & Precision Medicine (CAGPM). Dr. Woods is the Global Health lead for the Duke Tropical Conservation Initiative. Clinically, he is Chief of Infectious Diseases, and hospital epidemiologist for the Durham VA Medical Center. Dr. Woods is board-certified in internal medicine, infectious diseases, and medical microbiology.

Dr. Woods has co-authored over 140 peer-reviewed articles. His research focuses on development of novel diagnostic approaches to infectious disease and potential for interspecies transmission of pathogens. His genomic approach to harnessing the host response for diagnosis of infectious diseases has been called a paradigm shift in the field. He is particularly interested in augmenting medical microbiology capacity in the developing world and epidemiology of emerging and re-emerging infectious diseases.

June 3, 2017
6:15 p.m. - 7:15 p.m.

Keynote Address

KathleenRubinsKeynoteScience in Extreme Environments: Building Extraterrestrial and Earth-Based Research Capabilities
Kate Rubins, Ph.D; NASA Astronaut, Molecular Biologist

Dr. Kate Rubins was selected by NASA in 2009. Rubins completed her first spaceflight on Expedition 48/49, where she became the first person to sequence DNA in space. She spent 115 days in space and conducted two spacewalks. She holds a Bachelor of Science in Molecular Biology from the University of California and a Ph.D. in Cancer Biology from Stanford University Medical School Biochemistry Department and Microbiology and Immunology Department.

Dr. Rubins conducted her undergraduate research on HIV-1 integration in the Infectious Diseases Laboratory at the Salk Institute for Biological Studies. She analyzed the mechanism of HIV integration, including several studies of HIV-1 Integrase inhibitors and genome-wide analyses of HIV integration patterns into host genomic DNA. She obtained her Ph.D. from Stanford University and, with the U.S. Army Medical Research Institute of Infectious Diseases and the Centers for Disease Control and Prevention, Dr. Rubins and colleagues developed the first model of smallpox infection. She also developed a complete map of the poxvirus transcriptome and studied virus-host interactions using both invitro and animal model systems.

Dr. Rubins then accepted a Fellow/Principal Investigator position at the Whitehead Institute for Biomedical Research (MIT/Cambridge, Massachusetts) and headed a lab of 14 researchers studying viral diseases that primarily affect Central and West Africa. She traveled to the Democratic Republic of Congo to conduct research and supervise study sites. Work in the Rubins Lab focused on poxviruses and host-pathogen interaction as well as viral mechanisms for regulating host cell mRNA transcription, translation and decay. In addition, she conducted research on transcriptome and genome sequencing of filoviruses (Ebola and Marburg) and Arenaviruses (Lassa Fever) and collaborative projects with the U.S. Army to develop therapies for Ebola and Lassa viruses. Dr. Rubins has published and presented her work in numerous papers at international scientific conferences and in scientific journals.